Clinical Trial Update: Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase Ib study of Hepalatide (L47) in healthy volunteers has completed. The update notes the completion of the trial investigating safety and tolerability for c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Hepalatide (L47) (Hepalatide)

Snippet

Sponsor: Shanghai HEP Pharmaceutical Co., Ltd. | Conditions: Hepatitis B， Chronic | Phase 1 | Status: COMPLETED